Dexcom Inc. buy Royal Bank of Canada
Start price
25.10.24
/
50%
€69.04
Target price
25.10.25
€106.41
Performance (%)
-12.17%
End price
26.10.25
€60.64
Summary
This prediction ended on 26.10.25 with a price of €60.64. The price of Dexcom Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.17%. Royal_Bank_of_Canada has a follow-up prediction for Dexcom Inc. where he still thinks Dexcom Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dexcom Inc. | -3.029% | -3.029% | -24.512% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Dexcom Inc. diskutieren
DexCom, Inc. (NASDAQ: DXCM) had its price target lowered by analysts at Royal Bank of Canada from $120.00 to $115.00. They now have an "outperform" rating on the stock.
Ratings data for DXCM provided by MarketBeat
In the thread Trading Dexcom Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

